Wordt geladen...
The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin
The use of the anticancer drug doxorubicin (Dox) is limited by its cardiotoxic effect. The aim of this work was to study the effect of a new synthetic agonist of the galanin receptor GalR1-3 [βAla14, His15]-galanine (2–15) (G) on the metabolism, antioxidant enzyme activity, and cardiac function in r...
Bewaard in:
| Gepubliceerd in: | Acta Naturae |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
A.I. Gordeyev
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245963/ https://ncbi.nlm.nih.gov/pubmed/32477603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/actanaturae.10945 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|